These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15183074)

  • 21. Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia.
    Endo K; Katsumata K; Iguchi H; Kubodera N; Teramoto T; Ikeda K; Fujita T; Ogata E
    J Bone Miner Res; 1998 Sep; 13(9):1378-83. PubMed ID: 9738509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronotherapy of high-dose 1,25-dihydroxyvitamin D3 in hemodialysis patients with secondary hyperparathyroidism: a single-dose study.
    Tsuruoka S; Sugimoto K; Ohmori M; Kawaguchi A; Saito T; Fujimura A
    Clin Pharmacol Ther; 1999 Dec; 66(6):609-16. PubMed ID: 10613617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats.
    Tanaka Y; Nakamura T; Nishida S; Suzuki K; Takeda S; Sato K; Nishii Y
    J Bone Miner Res; 1996 Mar; 11(3):325-36. PubMed ID: 8852943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of calcitriol, 22-oxacalcitriol, and calcipotriol on serum calcium and parathyroid hormone gene expression.
    Naveh-Many T; Silver J
    Endocrinology; 1993 Dec; 133(6):2724-8. PubMed ID: 8243296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different effects of 22-oxacalcitriol and calcitriol on the course of experimental chronic renal failure.
    Sanai T; Tokumoto M; Hirano T; Okuda S
    J Lab Clin Med; 2002 Oct; 140(4):242-9. PubMed ID: 12389022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium supplementation does not reproduce the pharmacological efficacy of alfacalcidol for the treatment of osteoporosis in rats.
    Shiraishi A; Ito M; Hayakawa N; Kubota N; Kubodera N; Ogata E
    Calcif Tissue Int; 2006 Mar; 78(3):152-61. PubMed ID: 16525749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the mechanisms for the selective action of vitamin D analogs.
    Dusso AS; Negrea L; Gunawardhana S; Lopez-Hilker S; Finch J; Mori T; Nishii Y; Slatopolsky E; Brown AJ
    Endocrinology; 1991 Apr; 128(4):1687-92. PubMed ID: 2004595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of alendronate on bone resorption of autogenous free bone grafts in rats.
    Altundal H; Sayrak H; Yurtsever E; Göker K
    J Oral Maxillofac Surg; 2007 Mar; 65(3):508-16. PubMed ID: 17307600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two novel vitamin D receptor modulators with similar structures exhibit different hypercalcemic effects in 5/6 nephrectomized uremic rats.
    Wu-Wong JR; Kawai M; Chen YW; Wessale JL; Huang CJ; Wu MT; Nakane M
    Am J Nephrol; 2013; 37(4):310-9. PubMed ID: 23548814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 22-Oxacalcitriol attenuates bone loss in nonobese type 2 diabetes.
    Goto S; Fujii H; Kono K; Nakai K; Awata R; Yonekura Y; Hirata M; Shinohara M; Nishi S; Fukagawa M
    Bone; 2015 May; 74():153-9. PubMed ID: 25645030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.
    Smith DC; Johnson CS; Freeman CC; Muindi J; Wilson JW; Trump DL
    Clin Cancer Res; 1999 Jun; 5(6):1339-45. PubMed ID: 10389917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine.
    Brown AJ; Finch J; Grieff M; Ritter C; Kubodera N; Nishii Y; Slatopolsky E
    Endocrinology; 1993 Sep; 133(3):1158-64. PubMed ID: 8396012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypercalciuria due to combined growth hormone and calcitriol therapy in uremia: effects of growth hormone on mineral homeostasis in 75% nephrectomized weanling rats.
    Kainer G; Nakano M; Massie FS; Foreman JW; Chan JC
    Pediatr Res; 1991 Dec; 30(6):528-33. PubMed ID: 1805148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosing time-dependent effect of raloxifene on plasma fibrinogen concentration in ovariectomized rats.
    Tsuruoka S; Hasegawa G; Kaneda T; Maeda A; Fujimura A
    Chronobiol Int; 2008 Sep; 25(5):808-18. PubMed ID: 18780206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zinc nutritional status modifies renal osteodystrophy in uremic rats.
    Kimmel PL; Langman CB; Bognar B; Faugere MC; Chawla LS; Watkins DW; Malluche HH
    Clin Nephrol; 2001 Dec; 56(6):445-58. PubMed ID: 11770796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosing-time dependent effect of dexamethasone on bone density in rats.
    Takahashi M; Ushijima K; Hayashi Y; Maekawa T; Ando H; Tsuruoka S; Fujimura A
    Life Sci; 2010 Jan; 86(1-2):24-9. PubMed ID: 19903488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone.
    Saito H; Takeda S; Amizuka N
    J Steroid Biochem Mol Biol; 2013 Jul; 136():178-82. PubMed ID: 23069645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parathyroid hormone increases bone formation and improves mineral balance in vitamin D-deficient female rats.
    Toromanoff A; Ammann P; Mosekilde L; Thomsen JS; Riond JL
    Endocrinology; 1997 Jun; 138(6):2449-57. PubMed ID: 9165035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.